Brief: CytRx Corp announces amendment to definitive proxy statement for upcoming special meeting
13/09/2017 14:00
Sept 13 (Reuters) - CytRx Corp CYTR.O
* CytRx Corp announces amendment to definitive proxy
statement for upcoming special meeting
* CytRx Corp - amended definitive proxy statement with SEC
to include a 1-for-6 reverse stock split of company's authorized
common and preferred stock
Source text for Eikon: ID:nPn7mKyk9a
Further company coverage: CYTR.O
(((Bangalore.newsroom@thomsonreuters.com;);))
Recent news on LadRx
See all newsBrief: Ladrx Issues 2024 Update To Shareholders
Brief: LadRx Completes Non-Dilutive Financing Transaction For Up To $11 Mln With Xoma Corporation
Brief: LadRx Intends To Apply To List Stock On Nasdaq Under Symbol 'LADX'
Brief: LadRx Announces Review Of Strategic Alternatives, Provides Corporate Updates
Brief: CytRx Highlights Orphazyme's Update On Productive Meeting With FDA Regarding Arimoclomol In Niemann-Pick Disease Type C